Artwork

Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Assay Aids Diagnosis of Resistant Hypertension: John Lieske, M.D., and Sandra Taler, M.D.

11:49
 
Share
 

Manage episode 490482136 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

John Lieske, M.D., and Sandra Taler, M.D., explain how Mayo Clinic Laboratories' mass spectrometry assay helps evaluate patients for resistant hypertension. The test detects antihypertensive medications in urine, providing evidence of whether patients are absorbing their medications or whether a new treatment approach might be needed.

Speaker 3: (00:33)
Could you tell us a little about yourselves and your backgrounds?

Speaker 3: (01:41)
Dr. Taler, could you provide us with a brief background on resistant hypertension?

Speaker 3: (03:43)
Can you provide a little bit more background on patients who aren't taking their medications?

Speaker 3: (05:11)
How do physicians currently assess whether patients are taking their medications?

Speaker 3: (07:03)
Dr. Lieske, could you tell us how this new assay can be used to help physicians manage their patients with hypertension?

Speaker 3: (09:43)
Dr. Taler, can you tell us how doctors can use this new testing to manage their patients?

  continue reading

356 episodes

Artwork
iconShare
 
Manage episode 490482136 series 2908385
Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

John Lieske, M.D., and Sandra Taler, M.D., explain how Mayo Clinic Laboratories' mass spectrometry assay helps evaluate patients for resistant hypertension. The test detects antihypertensive medications in urine, providing evidence of whether patients are absorbing their medications or whether a new treatment approach might be needed.

Speaker 3: (00:33)
Could you tell us a little about yourselves and your backgrounds?

Speaker 3: (01:41)
Dr. Taler, could you provide us with a brief background on resistant hypertension?

Speaker 3: (03:43)
Can you provide a little bit more background on patients who aren't taking their medications?

Speaker 3: (05:11)
How do physicians currently assess whether patients are taking their medications?

Speaker 3: (07:03)
Dr. Lieske, could you tell us how this new assay can be used to help physicians manage their patients with hypertension?

Speaker 3: (09:43)
Dr. Taler, can you tell us how doctors can use this new testing to manage their patients?

  continue reading

356 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play